A multivariate analysis of IK target gene expression levels showed that the multivariate mean for primary cells from BCR-ABL+ ALL patients was not significantly different from that of normal bone marrow cells (MANOVA, Sum Contrast, F1, 194 = 0.768, P=0.382). The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.